Additional educational needs in children born to mothers with epilepsy, Journal of Neurology, Neurosurgery & Psychiatry, vol.70, issue.1, pp.15-21, 2001. ,
DOI : 10.1136/jnnp.70.1.15
Lamotrigine, carbamazepine and phenytoin differentially alter extracellular levels of 5-hydroxytryptamine, dopamine and amino acids, Epilepsy Research, vol.63, issue.2-3, pp.141-149, 2005. ,
DOI : 10.1016/j.eplepsyres.2005.02.002
A Rapid and Specific Assay for the Determination of Lamotrigine in Human Plasma by Normal-Phase HPLC, Therapeutic Drug Monitoring, vol.19, issue.1, pp.100-107, 1997. ,
DOI : 10.1097/00007691-199702000-00020
Antiepileptic drugs and apoptotic neurodegeneration in the developing brain, Proc. Natl. Acad. Sci. U.S.A. 99, pp.15089-15094, 2002. ,
DOI : 10.1073/pnas.222550499
Lamotrigine pharmacokinetic/pharmacodynamic modelling in rats, Fundamental and Clinical Pharmacology, vol.27, issue.5, pp.669-675, 2005. ,
DOI : 10.1038/sj.bjp.0703337
Mechanisms of Action of Antiepileptic Drugs, Current Topics in Medicinal Chemistry, vol.5, issue.1, pp.3-14, 2005. ,
DOI : 10.2174/1568026053386962
Effects of the antiepileptic drugs lamotrigine, topiramate and gabapentin on hERG potassium currents, Epilepsy Research, vol.63, issue.1, pp.17-25, 2005. ,
DOI : 10.1016/j.eplepsyres.2004.10.002
So-called ???cryptogenic??? partial seizures resulting from a subtle cortical dysgenesis due to adoublecortin gene mutation, Seizure, vol.11, issue.4, pp.273-277, 2002. ,
DOI : 10.1053/seiz.2001.0607
The teratogenicity of anticonvulsant drugs: a progress report, Journal of Medical Genetics, vol.39, issue.4, 2002. ,
DOI : 10.1136/jmg.39.4.245
Long-Term Neuropsychological Consequences of Maternal Epilepsy and Anticonvulsant Treatment During Pregnancy for School-Age Children and Adolescents, Epilepsia, vol.34, issue.9, 1999. ,
DOI : 10.1016/S0140-6736(68)91781-9
Modulation of neuronal migration by NMDA receptors, Science, vol.260, issue.5104, pp.95-97, 1993. ,
DOI : 10.1126/science.8096653
Lamotrigine: mechanisms of action, Antiepileptic Drugs. Lippincott Williams and Wilkins, pp.364-369, 2002. ,
GABA and glutamate depolarize cortical progenitor cells and inhibit DNA synthesis, Neuron, vol.15, issue.6, 1995. ,
DOI : 10.1016/0896-6273(95)90008-X
Neurotransmitters and Brain Maturation: Early Paracrine Actions of GABA and Glutamate Modulate Neuronal Migration, The Neuroscientist, vol.17, issue.3, pp.268-279, 2007. ,
DOI : 10.1177/1073858406298918
URL : https://hal.archives-ouvertes.fr/inserm-00483861
A Noncanonical Release of GABA and Glutamate Modulates Neuronal Migration, Journal of Neuroscience, vol.25, issue.19, pp.4755-4765, 2005. ,
DOI : 10.1523/JNEUROSCI.0553-05.2005
URL : https://hal.archives-ouvertes.fr/inserm-00484364
Glutamate Acting on AMPA But Not NMDA Receptors Modulates the Migration of Hippocampal Interneurons, Journal of Neuroscience, vol.26, issue.22, pp.5901-5909, 2006. ,
DOI : 10.1523/JNEUROSCI.1033-06.2006
URL : https://hal.archives-ouvertes.fr/inserm-00483918
Fetal Exposure to GABA-Acting Antiepileptic Drugs Generates Hippocampal and Cortical Dysplasias, Epilepsia, vol.305, issue.8, pp.684-693, 2007. ,
DOI : 10.1111/j.1528-1157.1999.tb00913.x
URL : https://hal.archives-ouvertes.fr/inserm-00384325
In utero antiepileptic drug exposure: Fetal death and malformations, utero antiepileptic drug exposure: fetal death and malformations, pp.407-412, 2006. ,
DOI : 10.1212/01.wnl.0000227919.81208.b2
Is There a Role for Therapeutic Drug Monitoring of New Anticonvulsants?, Clinical Pharmacokinetics, vol.48, issue.3, 2000. ,
DOI : 10.2165/00003088-200038030-00001
Clinical pharmacology and therapeutic use of the new antiepileptic drugs Fundamental & Clinical Pharmacology 15, pp.405-417, 2001. ,
Birth defects after prenatal exposure to antiepileptic drugs, The Lancet Neurology, vol.4, issue.11, pp.781-786, 2005. ,
DOI : 10.1016/S1474-4422(05)70224-6
Comparison of the effects of anticonvulsant drugs with diverse mechanisms of action in the formalin test in rats, Neuropharmacology, vol.48, issue.7, 2005. ,
DOI : 10.1016/j.neuropharm.2005.01.013
Lamotrigine: clinical efficacy and use in epilepsy, 2002. ,
Lamotrigine inhibits basal and Na+-stimulated, but not Ca2+-stimulated, release of corticotropin-releasing hormone from the rat hypothalamus, Psychopharmacology, vol.430, issue.Suppl 2, pp.386-392, 2006. ,
DOI : 10.1007/s00213-006-0539-4
Neuropsychological effects of exposure to anticonvulsant medication in utero, Neurology, vol.64, issue.6, pp.949-954, 2005. ,
DOI : 10.1212/01.WNL.0000154514.82948.69